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ABSTRACT
DNA Synthesis is a critical component in many biological and medical applications.
Unfortunately, the production of DNA is tedious, time consuming, and expensive. To accelerate
the production times and lower the cost, we take a closer look at the potential application of
digital microfluidics for this process.
Microfluidics involves manipulating small volumes of fluid (microliters). It takes
advantage of the relative dominance of forces such as surface tension and capillary forces at the
submillimeter scale. This allows for lower reagent consumption and shorter reaction times. The
technology is also portable and can accommodate for various functions to be performed on the
device itself. A particularly appealing focus of this field is Digital Microfluidics (DMF).
Digital Microfluidics (DMF) is a relatively recent technology praised for its fast analysis
times and small volume requirements (microliters). An obstacle to the production of DNA chains
using traditional methods of nucleotide synthesis is the requirement of acetonitrile, which can’t
consistently be manipulated on DMF. Another obstacle to overcome is the accurate production of
long chains of nucleic acids (3000 to 5000 base pair products), much longer than the DNA
products used in a typical ELISA assay. For the sake of this project we are partnering with
Nuclera Nucleics, a company based in the United Kingdom working on a next-generation DNA
synthesis and automation platform. The company has created a novel way of synthesizing DNA
using aqueous chemistry. Collaborating with them, we propose to build a DMF device that will
perform oligonucleotide synthesis. The first step towards this goal is to verify that DNA ligation
can be executed on a DMF device.
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This device will make DNA synthesis more accessible and significantly reduce production
times in the laboratory. This will lead to more advancements in the field of genetics, drug
delivery and other biomedical applications.
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1.0 INTRODUCTION
1.1 Background
Solid phase DNA synthesis is one of the most important protocols in health care and
medical research [1]. The accurate production of long chains of nucleic acids (3000 to 5000 base
pairs) requires long labor hours and is expensive, as laboratories still rely on the same traditional
methods of producing them [2, 3]. These chains can be employed to probe genomic libraries for
unique DNA sequences, or to engineer changes in a protein structure [4]. This creates a practical
bottle neck in a variety of critical applications, including gene expression profiling, genome
annotation and directed mutagenesis [2, 4]. It would therefore be beneficial to produce DNA
rapidly and at low cost. The work presented here was performed in partnership with Nuclera
Nucleics who have created a novel chemical method to accurately perform oligonucleotide
synthesis using aqueous chemistry. Since this process employs water in lieu of acetonitrile, the
advantages of digital microfluidic automation can be used to increase throughput of
oligonucleotides.
Microfluidics is the field involving the manipulation of fluids at the submillimeter scale. At
this scale, the relative importance of physical forces changes. Forces like surface tension and
capillary forces become dominant. It is an attractive technology since it leads to shorter reaction
times and lower reagent requirements, as well as portability and multifunctionality on one small
platform. An interesting focus of this field for the application of DNA synthesis is Digital
Microfluidics (DMF). Digital Microfluidics (DMF) consists of manipulating discrete droplets of
liquid by actuating electrodes contingent to them on the device (Figure 1.1). It is a portable
technology that provides results quickly and only requires small volume samples, as all droplet
1

Figure 1.1: Image of a DMF device with droplet operations performed: (i) dispensing,
(ii) merging, (iii) splitting, (iv) and mixing of microliter-sized droplets [26]
operations can be done on the DMF device directly [5]. It is also reprogrammable to suit the
procedure needed and can handle multiple reagents without increasing the fabrication complexity
of the device. It could be used to automate complex biological protocols like oligonucleotide
synthesis. DMF devices have not been used to automate solid phase oligonucleotide synthesis
because it typically requires the use of acetonitrile at high concentrations for higher yields [6],
which can only be manipulated consistently on DMF at low concentrations [7].
The first step towards achieving the goal of this partnership with Nuclera is to develop a
DMF device that allows for DNA ligation on its surface without adversely affecting it. This is
verified by merging and mixing droplets containing two separate bricks of DNA provided by the
industrial partner in two different settings. This experiment is first executed on the bench top
using an Eppendorf tube in order to get a reference for our next results, then on the digital
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microfluidic device by employing its droplet operation capabilities (dispensing, merging and
mixing). A DNA gel electrophoresis is then run, separately evaluating the weight of the ligated
bricks on bench and the ligated bricks on the digital microfluidic device. To confirm the success
of this experiment, the DNA bricks ligated on the bench and those ligated on the device will need
to have a similar electrophoretic migration, i.e. the same number of base pairs.

1.2 Literature Review
Oligonucleotide Synthesis
Oligonucleotide synthesis allows for the chemical production of long chains of nucleic
acids. The most proficient process to produce oligonucleotide is through the use of
phosphoramidite monomers [8]. A phosphoramidite monomer is a nucleotide surrounded by
protection groups: trityl, amine, hydroxyl and phosphate groups (figure 1.2). These protection
groups ensure the formation of the desired product and inhibit any fouling or side reactions.
There are four main stages in the synthesis cycle: deprotection, coupling, capping and oxidation.
The first step of DNA synthesis is deprotection. The trityl group is removed by trichloroacetic
acid, leaving a hydroxyl group to react with the next base added. The second step is coupling.
Tetrazole is employed to increase coupling efficiency. It is a weak acid that attacks the
phosphoramidite nucleoside to form a tetrazolyl phosphoramidite intermediate. The latter will
react with the hydroxyl group left after deprotection. The next step is capping. An acetylating
reagent composed of acetic anhydride and N-methylimidazole is added. This reagent essentially
gets rid of coupling failures by irreversibly capping the oligonucleotides concerned. The last step
is stabilization. Water and Iodine are added. This leads to the oxidation of the phosphide into
phosphate, stabilizing the bond. The steps are then repeated for each nucleotide (figure 1.3).
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Figure 1.2: Protection groups in a phosphoramidite monomer [8]

Oligonucleotide synthesis is an important process for a variety of biological and medical
applications [9]. It is employed as primer for DNA sequencing or amplification, antisense
oligonucleotides, and interfering RNA [8]. Each oligonucleotide is custom made to fit the needs
of a specific research procedure [8]. Oligonucleotide synthesis is also crucial in the study of
heritable gene regulation (epigenetics) [9]. It can allow further cataloging of genome-wide DNA
methylation patterns, which shows specific modifications of the function and expression of genes
[10]. Unfortunately, there are still obstacles to overcome with Oligonucleotide synthesis. It
typically requires long hours of preparation and manipulation in laboratories [11]. One of the
major cost problems is the inability to lower the reagent consumption and reduce material waste
without in turn affecting the yields, making it very expensive to produce oligonucleotides [2].
Nuclera Nucleics proposes a protocol for accurately producing long DNA chains using highly
engineered enzymes, discussed further in section 3.3.
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Figure 1.3: Oligonucleotide synthesis using phosphonamidite, established as the
method of choice [40]

DNA ligation is the process of joining two linear fragments of DNA with covalent bonds
(figure 1.4). A ligase is employed as a catalyzer to help form covalent bonds and repair breaks in
nucleic acid chains. It is an essential process in gene applications such as gene cloning and DNA
or RNA synthesis [12].
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Figure 1.4: Traditional DNA ligation process: (1) Two bricks of DNA on left and right,
(2) Ligase introduced to form covalent bonds between the two DNA
fragments, and (3) The two DNA fragments are now merged into one bigger
DNA brick [41]
The ligation process is typically done in vitro using commercial DNA kits that require a large
sample volume (~15µL), and can take up to several hours of labor to complete. The commercial
kits available are expensive and can only synthesize up to 1000 base pairs [10], so there is
currently no commercial solution to fulfill the needs of laboratories looking to work with longer
oligonucleotide chains. Scientists have to purchase separate chains and assemble them
themselves to achieve the number of base pairs required. It has been reported that the standard
procedures result in a waste of 85% of the DNA and enzyme/buffer volume (figure 1.5) [13]. A
potential solution to these issues would be to apply the concept of microfluidics, specifically
digital microfluidics, to oligonucleotide synthesis.
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Figure 1.5 : Comparison of the volume of reagent usage for transformation in three
operating methods [13]
Digital microfluidics
The domain of microfluidics concerns the manipulation of fluids at the submillimeter
length scale. It is an attractive technology as the small size and automatability of microfluidic
devices provide advantages like shorter reaction times, low reagent requirement and function
variety on a standalone platform [14]. It eliminates the usual expensive bench top biomedical
devices needed to conduct a simple clinical test. It allows for faster analysis, portability, and
small volume samples, as operations are done directly on the microfluidic device [5]. It is also
versatile and reprogrammable to suit the assessment needed. It is particularly appealing as the
relative importance of different forces change when nearing microscale. Indeed, the surface
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Figure 1.6: Microchannel based microfluidic device for cell culture: (1) Cells are loaded
into the device and flowing through the growth chambers in the middle, (2)
Fresh media is infused with the growth chamber valves (isolation valves) closed
to flush out any cells remaining in the channels, (3) chemostat conditions
created by flowing media with the isolation valves open vs compartmentalized
growth where isolation valves are closed and oil is infused into the main
channels [17]
tension and capillary forces become dominant at the microscale. This opens the door for a
myriad of applications with high analytical throughput [15]. As such, it is possible to passively
pump fluids in microchannels without the use of an actual pump [16]. It also presents potential
solutions for point of care testing, medical diagnostics, and biology research. Microfluidic
devices can also be used to mimic conditions for cell culture, controlling the environment of
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those cells directly in the device [17] (figure 1.6). In drug delivery for instance, microsystems
equipped with sensors are capable of delivering precise drug doses [18]. Integrated chemical
analyzers may be used to analyze a whole blood sample of only 1μL for HIV and syphilis in a
matter of minutes instead of hours [19]. Microfluidics are also employed to detect a known
prostate cancer biological marker, Prostate Specific Antigen (PSA) [20]. An interesting emerging
field is Digital Microfluidics (DMF), which allows active fluid handling of individual droplets
over an array of electrodes.
Digital Microfluidics (DMF) is a relatively recent microfluidic platform that manipulates
individual droplets of fluid using electric fields. DMF devices consist of droplets of liquid above
an array of electrodes coated with a dielectric and hydrophobic layers [5, 24–26]. As opposed to
the passive use of capillarity in microchannels [19, 20](Figure 1.6), droplets are manipulated by
electrowetting on dielectric (EWOD). Electrodes contingent to the droplet are actuated to
displace it. The electric field created will change the interfacial energy between the droplet and
the surface, reducing the contact angle and “wetting” the surface [25, 27] (Figure 1.7).
The physics of electrowetting help understand the operation of a DMF device. Berge
combined Lippmann’s law (equation 1) with Young’s equation (equation 2) to relate the contact
angle and the electric potential, leading to the Lippmann-Young equation (equation 3) [25]:
𝑐

𝛾𝑆𝐿 = 𝛾𝑆𝐷𝐿 − 2 𝑉 2

(1)

γSL is the solid-liquid interfacial tension when the voltage is applied, and γSLD is the interfacial
tension when there is no voltage. C is the capacitance per unit area of the dielectric layer
covering the electrodes in the DMF device, and V is the voltage applied.
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𝛾𝑆𝐿 = 𝛾𝑆𝐺 − 𝛾𝐿𝐺 cos 𝜃
1 1

cos 𝜃 = cos 𝜃0 − 𝛾

𝐿𝐺 2

(2)

𝐶𝑉 2

(3)

In the above equations, γSG is the solid-gas interfacial tension, γLG is the liquid-gas interfacial
tension and θ0 and θ are the contact angles without and with the voltage applied, respectively.
When applying the voltage to the adjacent electrode, charges in the droplet gather at the liquidsolid-gas interface. This leads to a decrease of the liquid-solid interfacial tension. The driving
force is the result of electrostatic forces varying the apparent wettability of the system [26].
DMF devices reduce diffusion times by automating the process with simple and compact
equipment, and reducing reagent consumption overall [27]. This leads to faster analysis and
lower cost. The liquid can be surrounded by a carrier oil (e.g. silicone oil) [28], or by air [29]. As
such, DMF is an attractive candidate for clinical applications on biomedical devices, especially
point of care testing and immunoassays [5]. DMF enables each droplet to be controlled
individually, without the need for physical elements such as valves or mechanical mixers [26].

Figure 1.7: EWOD with effect on contact angle in an open device (left), and a general
structure of a closed DMF device (right)
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A final point worth noting is that the fabrication of DMF devices can be slow and
expensive. It generally requires cleanroom facilities for microfabrication [24]. Recently, lowcost inkjet fabrication methods have been used to create DMF devices with similar performance
to cleanroom fabricated devices. Using a consumer-grade inkjet printer, a paper with electrodes
can be printed using metallic ink. The device is assembled using glass slides, and the upper and
lower plates are coated with layers of Teflon, ITO and PFC [30]. This makes inkjet-printing of
DMF devices an attractive method for rapid prototyping as it effectively reduces costs and time
compared to cleanroom fabrication methods [31]. This study takes a closer look at operations on
inkjet-printed microfluidic devices, as this allows several designs to be manufactured and tested
out in a shorter time than the cleanroom fabricated ones.
1.3 Contributions
DNA synthesis is a bottleneck in many biological research applications and medical
diagnostics. The current methods of synthesizing DNA are costly and time consuming. It would
therefore be beneficial to figure out a way to synthesize DNA quickly and cheaply. The
application of digital microfluidics to automate this process on a portable device gives rise to the
possibility of achieving accurate results in a shorter amount of time. It also allows for the
significant reduction of reagents consumption since only microliter droplets are used. Partnering
with Nuclera Nucleics, we proposed to build a DMF device that would be able to perform
oligonucleotide synthesis using aqueous chemistry instead of the use of acetonitrile, previously
never executed. By performing DNA ligation on a DMF device, this demonstrates that DNA
synthesis is possible on a DMF device using Nuclera’s chemical process. This will open the
doors for a more accessible means of producing DNA, thus paving way for further innovations in
medical and biological applications.
11

2.0 RESEARCH QUESTION
The primary goal of this thesis is to answer the following question: can DNA ligation be
executed on a digital microfluidic device using Nuclera’s novel aqueous protocol? DMF
DNA ligation will be benchmarked against the bench top biochemical process following a
protocol provided by Nuclera. Thus, if successful on a digital microfluidic device, this protocol
could revolutionize the way we synthesize DNA, as it provides a cheaper and faster way of doing
so. This study is just the first step towards achieving an automated DMF platform for
oligonucleotide synthesis.
All the operations performed were performed on inkjet-printed digital microfluidic devices,
while another student in the DMFL (Hee Tae An) performed the same process on cleanroom
fabricated DMF devices. A secondary goal of this work is to determine if low-cost IJP devices
can provide similar results as cleanroom devices. These inkjet-printed DMF devices are more
accessible as they are easier to fabricate, and do not require any expensive equipment for
manufacturing: no chemical process is involved such as etching or chemical deposition, and no
precautions have to be taken (cleanroom attire). The low-cost DMF devices can be built in the
DMFL directly using common equipment such as a printer and glass slides.
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3.0 EXPERIMENTAL METHODOLOGY
This section is broken down into three major categories: device fabrication, device
operation, and experimental analysis. The device fabrication section will mainly comprise of the
device manufacturing procedures and the evolution of the designs adopted over time. The device
operation section will explain the experimental design along with the protocol employed for
DNA ligation on and off the device and the droplet composition. The experimental analysis will
discuss the process and equipment for running the gel electrophoresis in order to evaluate the
DNA migration.

3.1 Device Fabrication
A DMF device generally consists of two substrates, a conductive layer, hydrophobic and
dielectric layers. The breakdown of the components for both bottom and upper part of a DMF
device is as follows:
➢ Bottom plate:
o Substrate
o Conductive layer
o Dielectric Layer
o Hydrophobic layer
o Spacer
➢ Top plate:
o Substrate
o Conductive layer
o Hydrophobic layer

13

Figure 3.1: General structure of a DMF device

The hydrophobic and dielectric layers on the bottom part of our devices were spin coated in the
following order:
1- 6% Teflon Layer (hydrophobic layer ~100nm thick) (figure 3.3)
2- SU-8 Layer (dielectric layer ~4.4μm thick) (figure 3.4)
3- 6% Teflon Layer (hydrophobic layer ~100nm thick) (figure 3.5)

A first hydrophobic layer of Teflon was necessary as the SU8 film did not bond well to the
printing media [32]. Kapton tape was used to stick the printing media on the glass slide once the
electrodes were printed and dried at room temperature for 24 hours. The bond pads were also
covered with Kapton tape, and were removed after the spin coating is done. This keeps the bond
pads exposed to be able to actuate the corresponding electrodes.
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The top part of the device will also feature the glass slide (50x25mm) substrate coated with
ITO, directly procured from Delta technologies (Surplus part # X172). A layer of Teflon is spin
coated on top of the ITO layer (figure 3.2). A small patch was scratched off after coating in order
to ground the device by using a piece of copper tape linked to the ITO layer. During the
assembly of the top and bottom parts of the device, double sided tape of approximately 100µm
thickness was employed as spacers (figure 3.6).
ITO (dielectric layer) as procured
from supplier
Glass substrate

Spin coat Teflon for 1 minute at 2000RPM

Bake on hotplate for 10 minutes at 160C

Let cool for 1-2 minutes

Teflon (hydrophobic layer
~100 nm thick)

Figure 3.2: DMF device top plate fabrication flow chart
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Inkjet-printed Electrodes on printing media

Glass Substrate

Spin coat Teflon for 1 minute at 2000RPM

Bake on hotplate for 10 minutes at 160C

Let cool for 1-2 minutes

Teflon (hydrophobic layer
~100nm)

Figure 3.3: DMF bottom plate fabrication flow chart part 1 (first hydrophobic layer)
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Spin coat SU8 for:
•
•

10 seconds at 500 RPM
30 seconds at 4000 RPM with
300 RPM acceleration

Bake on hotplate for 2 minutes 30 seconds at
95C

ELC-UV 500
Curing
Chamber

Expose to UV for 30 seconds

Bake on hotplate for 1 minute at 95C

Bake on hotplate for 3 minutes at 150C

Let cool for 1-2 minutes

SU8 (dielectric layer
~4.4μm thick)

Figure 3.4: DMF bottom plate fabrication part 2 (dielectric layer)
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Spin coat Teflon for 1 minute at 2000RPM

Bake on hotplate for 10 minutes at 160C

Let cool for 1-2 minutes

Teflon (hydrophobic layer
~100nm thick)

Figure 3.5: DMF bottom plate fabrication flow chart part 3 (second hydrophobic layer)

Figure 3.6: DMF device after assembly of top and bottom parts
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This fabrication process is faster than the conventional cleanroom fabrication procedure
used by my DMFL colleague Hee Tae. Indeed, cleanroom fabrication involves steps using
several equipment in order to first etch the substrates, then sputter the electrodes (Aluminum),
perform a first level lithography to develop the substrates, then etch the sputtered electrodes, dice
the substrate, then perform a second level lithography to develop the dielectric layer and finally
spincoat the hydrophobic layer. This process can take several hours to several days due to the
scheduling of the equipment. This compares to using only an inkjet-printer, a spincoater and a
UV cure chamber outside the cleanroom for manufacturing IJP devices. Also, the IJP devices
only require nitrile gloves for handling as the fabrication is done directly in the DMFL whereas
the cleanroom has strict precaution and protection guidelines (protective equipment).
Electrodes were designed in Adobe Illustrator. The primary design comprised of two
reservoirs and six transport electrodes only. For the first try, a simple layout has been chosen to
facilitate testing and observations. The first print with three separate electrode designs had very
spaced out electrodes (0.75mm) to get familiar with the process. A set of these three designs with
0.75mm spacing was created and printed (figure 3.7). The reservoirs provide the supply to create
a droplet on the DMF device. A C-shape reservoir was mainly adopted. An L-shape was also
created to compare the ease of droplet creation on the device. Continuity between the electrodes
was checked using a multimeter to determine whether electrodes were shorted.
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Figure 3.7: L-shape vs C-shape reservoirs close-up
The minimum spacing between all elements on the IJP electrodes was chosen from
literature to be at least 0.15mm, or 150μm, to keep the printed patterns loyal to the ones designed
and to reduce the probability of shorts happening between electrodes [30]. Two different shapes
of transport electrodes were drawn: square and star shaped electrodes inspired by multiple works
from the Wheeler Microfluidics Laboratory [7, 26, 32] . A set of z-block electrode designs was
initially drawn and printed as well (figure 3.8), but was dropped for the next iteration.
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Figure 3.8: 3 designs before printing (left): star (top), square (middle), and z-block
(bottom), and after printing (right)

The electrodes were printed using an Epson C88+ Stylus printer (figure 3.9) with Novacentrix
JS-B25P silver ink with particle size 83 nm, on a Novacentrix Novele printing media, a PET
based substrate with porous coating. The printer settings were the following:
-

Paper type: premium glossy photo paper

-

Print quality: Best

-

Image type: Line art
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Figure 3.9: Pictures of Epson C88+ Printer (left), the silver ink (middle) and the polymer
printing media used (right).

The next IJP electrodes printed had an electrode gap of 200μm (figure 3.10). The smaller
distance helped execute droplet movement but was limited by the printer resolution. Printed
electrodes were reported in literature to be closer than the distance initially set on the design,
while the traces linking the electrodes to the bond pads are reported to be thicker than drawn
[30]. The reservoir electrodes were 20mm by 12mm roughly, and the transport electrodes were
1.5mm by1.5mm, while the traces were drawn 150μm thick.

Figure 3.10: Electrodes printed with 200μm spacing between square electrodes (left) and
between star electrodes (right)
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Difficulties with droplet splitting from the reservoir were encountered with this design, as the
reservoir electrode was deemed too big compared to the transport electrode (figure 3.11). The
size of the reservoir directly affects the splitting of the water droplet placed on it as a supply. The
“cutting” of the supply droplet to dispense smaller droplets is largely dependent on the size of the
transport electrode as well. Larger electrodes with a smaller electrode gap have shown to make
dispensing easier [34]. The reservoir presented here is asymmetrical, and causes the supply
droplet to “choose” the more advancing side of the reservoir, i.e. the side closer to the transport
electrodes. This leads to inconsistent splitting and a tail formation, as seen (figure 3.11). The
shape of the reservoir electrodes was also seen to affect the droplet necking position leading to
the droplet cutting [35]. Indeed, the consistency location of the pinch-off is stated as a crucial
factor in droplet splitting and relies on several parameters such as the volume of the reservoir
drop, the surface properties and the applied voltage. It has also been speculated that the irregular
droplet dispensing is due to uncontrolled internal pressure difference between the liquid in the

Tail Formation

1.5mm

Figure 3.11: Tail formation after droplet splitting failure on a square electrode design
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Figure 3.12 : Conventional splitting method in EWOD devices with related issues (left)
and a potential solution for consistent splitting using a TCC reservoir (right)
[35]
reservoir and the front of the liquid finger. This uncontrolled pressure difference varies the
location of the front menisci of both the reservoir droplet and the dispensed droplet before
cutting (figure 3.12).
Following this trail on droplet splitting, a new “TCC” reservoir electrode design was
adopted [35]. It comprises four patterned electrodes, designed to help neck the droplet at the
same location every time (figure 3.12). The designs were magnified as they were meant for
inkjet-printed devices. The reservoir electrodes dimensions are, from far to center: 11mm x
6mm, 6.8mm x 4mm, 6.2mm x 3mm. The two variations of this pattern, one with a square center
electrode (2mmx2mm) and one with a drop shaped electrode were drawn (figure 3.13).
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Figure 3.13: Design with TCC patterned electrodes for easier splitting adapted for IJP
devices

Difficulties were encountered with the TCC design as well. These designs resulted in a
significant number of shorted electrodes due to the unpredictability of the inkjet printer’s output
of ink (figure 3.14). The square shaped center electrode design was the most successful, as it
presented the least shorts in the designs created.

Figure 3.14: Pictures showing shorts between electrodes due to ink overlapping
electrodes on the drop-shaped pattern (left) and the square pattern (right).
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Figure 3.15: Design of interdigitated TCC electrodes in two variations: triangle (left) and
square (right)
The next step in the design variation consisted of interdigitating the reservoir electrodes in order
to help droplet splitting and facilitate droplet movement. Two patterns of interdigitation, square
and triangle, were tried (figure 3.15). Electrodes were also drawn bigger in order to facilitate
dispensing: 2mm by 2mm. A last design attempt consisted of adapting a design from Dixon et al,
2016 [30], presenting different shapes for the reservoir and dispensing electrodes (figure 3.16).
The transport electrodes were star shaped. The elongated dispensing electrodes are drawn to help
cut the droplet by elongating it from the reservoir onto the transport electrodes.

Figure 3.16: Design adapted from Dixon et al with a star transport electrode design for
inkjet-printed devices [30]
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Moving the droplets on the transport electrodes was successful on the interdigitated
designs. Most of the star designs that were printed manifested too many shorts to be usable. This
suggests that the design had probably not been adapted well to the IJP device design
requirements. Dispensing the droplet from the reservoir wasn’t successfully consistently
executed. Various factors such as the inconsistencies in printing and spin coating presented
obstacles (figure 3.17).

Tail Formation

Figure 3.17: Splitting failure on the TCC interdigitated design (square). The beads
shown by the arrows (spincoating inconsistencies) present on the surface of
the device pin the droplet and inhibit its movement.
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1

2

4

5

3

Figure 3.18: Dispensing a 4μL droplet from a TCC reservoir in a square shaped TCC
designs with (1-3) elongation of the supply droplet in the reservoir then (45) cutting of the droplet

However, the TCC pattern design has shown promise for splitting (figure 3.18).

3.2 Device Operation
The equipment used in the experiments discussed remained unchanged throughout the
course of the study (figure 3.19). The apparatus employed consisted of:
-

A signal generator (NI PXI 5402)
Both housed in NI PXI 1033 chassis

-

A digital multimeter (NI PXI 4072)

-

A voltage amplifier (Trek PZD700A)

-

IJP DMF device with pogo pin board controller
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The voltage and frequency desired were set on the signal generator, which had a maximum input
value of 5V peak-to-peak (5Vpk), then ramped up by a factor of 200 through the voltage
amplifier and sent to the DMF device. The amplifier sends another signal that is stepped down
by a factor of 200 to the digital multimeter which reads the voltage root-mean-squared value
(VRMS) coming out the amplifier, in order to make sure the voltage applied is correct. The images
and videos were captured using a Zeiss stereo discovery V8 and a Zeiss axiocam for low-light
and fluorescent applications (figure 3.20)

Figure 3.19: Signal generator with digital multimeter in chassis (left), voltage amplifier
(middle), and pogo pin board from the Wheeler laboratory to control the
DMF (right)
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Figure 3.20: Zeiss stereodiscovery V8 microscope (left) and Zeiss axiocam MRm(right)

The objective of this study was to test whether DNA ligation can be executed on an inkjetprinted digital microfluidic device (figure 3.21).

Figure 3.21: Operations to be performed on the IJP DMF for DNA ligation (courtesy of
Dr. Schertzer)
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The operations on the IJP device consisted of dispensing two droplets from two reservoirs
containing two different bricks of DNA, then merging both daughter droplets to initiate the
ligation, and finally mixing them by moving the merged droplet back and forth on the device.
Each type of operations can be broken down into steps explaining how they get executed on the
device. There are similarities when it comes to moving and merging on each device, as the
designs don’t much affect the moving sequence of the droplet much. The electrode contingent to
the droplet is actuated in order to move the droplet. Dispensing changes depending on the design,
as some designs have more reservoir electrodes dedicated to dispensing droplets. An example of
electrode actuation can be found below (figure 3.22) for each design type: the square type design
will have the same actuation sequence as any other design with one reservoir electrode such as
the star design, and the TCC designs will have the same actuation sequence as its interdigitated
variations. The electrodes were actuated manually by applying an AC voltage to the bond pad
associated to them or by activating the Labview sequence corresponding to the wished operation:
dispense/create and move/merge/mix (Appendix A). Applying voltage manually was crucial
during the course of this study as the geometry of the devices kept changing and so did the
applied voltages, as described in table 4.1. It permitted to try out different voltages and test the
upper and lower limits of the devices fabricated. Preliminary feasibility tests using deionized
water droplets has been done in order to verify that the designs used can perform the operations
successfully and repeatably, and the voltages applied are within operational range of the device.
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(a)

(b)

(c)
(1)

(2)

(3)

(4)

(5)

Figure 3.22: Actuation sequence (1-5) for droplet dispensing on a square design IJP (a) and
on a variation of TCC design (b), and a general actuation sequence for moving
droplets on the transport electrodes from left to right (c)
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3.3 Ligation and Gel Electrophoresis
This part of the experiment can be broken down into simple steps for three different
scenarios:
1. Ligation
i.

Bench experiment (Eppendorf Tube):
(a) Droplet containing DNA brick 1
(b) Droplet containing DNA brick 2
(c) Ligation in Eppendorf tube

ii.

Merging on DMF device experiment:
(a) Droplet containing DNA brick 1
(b) Droplet containing DNA brick 2
(c) Merge both droplets – ligation on DMF
(d) Extract merged droplet for incubation in Eppendorf

iii.

Merging and mixing on DMF device experiment:
(a) Droplet containing DNA brick 1
(b) Droplet containing DNA brick 2
(c) Merge both droplets
ligation on DMF
(d) Move merged droplet back and forth to mix
(e) Extract merged and mixed droplet for incubation in Eppendorf
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2. Two step incubation in Eppendorf tube:
i.

30 minutes at 37C

ii.

10 minutes at 70C

3. Gel electrophoresis:
i.

Place harvested droplets after incubation in gel and run gel electrophoresis

ii.

Examine results using fluorescent scanner
The bench top ligation protocol was provided by the industrial partner. It was tested on the

bench first for confirmation of successful ligation, before altering the protocol to adapt it to the
digital microfluidic device’s operations. The initial mixing volume was of a total of 20μL and
contained:
Table 3.1: Reagents present in initial mixture for bench top DNA ligation
Reagent

Volume (µL)

DI Water

10.5

T4 DNA ligase buffer (10X)

1.2

Brick 1 (5µM)

4.0

Brick 2 (5µM)

4.1

T4 DNA ligase

0.2
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This was modified with the help of Dr. Michel from the College of Science to perform a simpler
yet successful ligation on the bench, while keeping some of the proportions of the mixture. The
following mixture was used for bench procedure in an Eppendorf tube:
Tube 1: 1μL of Brick 1 + 4µL of DI Water – (5µL)
Brick to total volume ratio 1:4

Tube 2: 1µL of Brick 2 + 4μL of DI Water – (5µL)
Following the bench ligation, the mixture was incubated at room temperature for one hour.
Proteinase K and calcium chloride were added to the mixture, and incubated for 30 minutes at
37C in an air incubator then 10 minutes at 70C in a water bath. This step insured the elimination
of any bound T4 DNA Ligase, which would cause aberrant DNA electrophoretic migration.
The DMF procedure required the inclusion of a surfactant to limit biofouling and help the
droplets move easier as proteins and other biological material tend to stick to the surface of the
device. Tween 20 at 0.1% concentration per volume was employed as a surfactant, using the
following proportions:
Tube 1: 5µL of Brick 1 + 2.5µL Tween 20 (1%) + 17.5µL DI Water – (Total volume = 25µL)
Tube 2: 5µL of Brick 2 + 2.5µL Tween 20 (1%) + 17.5µL DI Water – (Total volume = 25μL)
The droplets manipulated on the device were taken from those prepared solutions and harvested
off once the mixing procedure and incubation at room temperature on the device were done. The
two-step incubation (37C and 70C) on the DMF device directly has been attempted, but a
decrease in droplet areas due to evaporation over the course of this incubation discouraged this
procedure (figure 3.23). A wet sponge was used under the device to try and decrease the
evaporation rate of the droplets by increasing the humidity of its environment.
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Figure 3.23: Droplet area differences for 1μL droplet and 2μL droplet before incubation
(left), after incubation at 37C (middle), and after incubation at 70C (right).

After the incubation, the DNA gel electrophoretic migration could be examined. In order to
execute this process, an agarose gel at 2% was prepared and 2µL of ethidium bromide was
added. It was then loaded into the electrophoresis rig and allowed to cool for 30 minutes.
Four solutions are prepared for the gel run:
1) 9µL DI water + 2 μL Dye (Purple) + 1μL Brick 1 (prepared) - (Total Volume=13μL)
2) 9µL DI water + 2 μL Dye (Purple) + 1μL Brick 2 (prepared) - (Total Volume=13μL)
3) 9µL DI water + 2 μL Dye (Purple) + 1μL Ligated (on/off device) - (Total Volume=13μL)
4) Ladder Solution: 1 μL Ladder + 1 μL Dye + 4 μL DI Water – (Total Volume=6μL)
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The gel was run at 95V for 50 minutes (figure 3.24), and was analyzed in a fluorescent scanner
set for ethidium bromide. The electrophoretic migration of the DNA bricks from the negative to
the positive in the solutions prepared for the gel run inform us of whether the ligation was
successful. The bench experiment performed initially served as a reference for future ligations. A
process flow chart for the ligation protocol can be found in figure 3.25.

Figure 3.24: Gel electrophoresis rig + gel comb (left) and the cover with the anode and
cathode (right)

37

DNA Brick 1

DNA Brick 2

Incubation at room
temperature for
one hour

Ligated DNA

Incubation on device at
room temperature for
one hour, then harvest of
droplet in Eppendorf
tube for next incubation

Ligated DNA

2 Step incubation:
▪ Air incubator at
37C for 30
minutes
▪ Water bath at 70C
for 10 minutes

Gel electrophoresis
Figure 3.25: Process for DNA ligation on bench and on device, followed by incubation and
gel electrophoresis
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4.0 RESULTS AND DISCUSSION
This section will discuss results obtained during this study. The effects that certain
parameters, such as the design of the device and the droplet size, have on the device operations
are investigated. We will examine the effect of the design on the voltages applied on the devices,
and note the droplet volume used for the operations on each of those devices.

4.1 Preliminary testing with DI water droplets
The evolution of designs throughout this study sought to improve device operations. As
such, the manufacturing yields relating to each design represented in Table 4.1 help understand
which designs are “favorable” for IJP devices.
Table 4.1: Production yield of devices by design

Square
TCC Square
TCC Droplet
TCC Inter Square
TCC Inter Triangle
Star

Printed
36
12
12
24
16
16

Coated
22
7
7
14
7
0

Usable
14
4
3
11
3
0

Final Yield (%)
38.9
33.3
25
45.8
18.8
0

The above table shows the devices with the most yield were the initial square designs and
the TCC interdigitated square designs, with respective yields of 38.9% and 45.8%. Once the
designs were printed, they were tested for shorts between electrodes by checking for continuity
with a multimeter. Factors such as device geometry, design complexity and printing orientation
were among the main reasons for a variation in reliability and consistency in printing. Indeed, the
TCC droplet, the TCC interdigitated triangle and the star designs had the least yield as the
droplet shape, the interdigitated spikes, and the star were not “printer friendly” designs, showing
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too many shorts. Most of the TCC designs manifested too many shorts due to the complexity of
the design. The square design printing improved by switching the design orientation to vertical to
“help” the printer and minimize the overlapping of ink between electrodes. Those deemed to
have too many shorts to perform the device operations (dispense, split and/or move, merge, mix)
were not coated. Additionally, many devices were unusable after the spin coating stage due to
the presence of solid beads on the surface of the device, as shown in figure 3.17. These beads pin
droplets and make moving them more difficult. The cause of this phenomenon has not been
discovered during this study.
Table 4.2: Test matrix for voltage ranges and operation success on each device type
Design

Operation Performed Frequency Applied (kHz)
Dispense/Split

Square
Move/Merge/Mix
Dispense/Split
TCC Square
Move/Merge/Mix
Dispense/Split
TCC Droplet
Move/Merge/Mix
Dispense/Split
TCC interdigitated square
Move/Merge/Mix
Dispense/Split
TCC interdigitated triangle
Move/Merge/Mix
Dispense/Split
"Wheeler" Star
Move/Merge/Mix

1
10
100
1
10
100
1
10
1
10
1
10
1
10
1
10
1
10
1
10
1
10
1
10
1
10

AC Voltage Applied (VRMS)
Min
Max
73.4
96.1
73.4
96.1
91.2
120
65
95.3
65
95.3
82.6
112
52.1
74.3
52.1
74.3
46.4
74.3
47.8
77.8
51.3
71.2
51.3
73
46.4
75.9
43
76
57.8
71
60.5
73.2
54.2
60
61.3
85.3
71.2
82.2
76.9
85
68.4
72.7
71
81.8
NA
NA
NA
NA
NA
NA
NA
NA

Success?
Yes*
Yes*
Yes*
Yes
Yes
Yes
Yes*
Yes*
Yes
Yes
No
No
Yes*
Yes*
No
No
Yes
Yes
No
No
Yes
Yes
No
No
No
No

(*conditional success, not consistently repeated)
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Above are the results for testing the voltage ranges for each device, with the observation of
whether operations can be executed repeatedly. In order to test the capabilities and limits of the
printed devices, the range of voltages that could be applied for each design was examined in
Table 4.2. These voltages range from the lower limit voltage where droplet movement was
detected to the upper limit where electrolysis was encountered. Device operations are tested
within those ranges and “ideal” droplet volumes for each type of operation have been noted on
each device after repeated trials of different volumes. These preliminary tests were executed
using DI water droplets to gauge the minimum volume needed to perform operations with
droplets containing the DNA material for ligation.
During those tests, the volume of the droplet needed to execute the operations was noted in the
table below:
Table 4.3: Droplet volumes chosen for each operation after repeated trial of the operation
Device

Operation Droplet Size (μL)

Dispense
Move
Dispense
TCC Square
Move
Dispense
TCC droplet
Move
Dispense
TCC inter square
Move
Dispense
TCC inter triangle
Move
Dispense
"Wheeler" Star
Move
Square

4.5
2
4
1.5
4
1.5
4
2
4
2
NA
NA

As seen in the tables above, the star design adapted from Dixon et al [30] was not viable to
perform any of the operations. Sources of error may include the adapted design dimensions not
being suitable for the inkjet-printing resolution, as many electrodes were shorted after printing.
Dispensing/splitting a droplet from the reservoir has not been successfully and consistently
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executed repeatedly. Moving/merging/mixing was successfully repeated on the interdigitated
variations of the TCC design. These devices were used to perform the ligation by merging
(figure 4.1) and mixing (figure 4.2) the droplets containing biological material. The droplets
were pipetted on the transport electrodes for manipulation on the device.

Figure 4.1: Merging of two droplets containing DNA material for ligation on a TCC
interdigitated square device (from left to right)

Figure 4.2: Mixing of the merged droplet containing DNA material for ligation on a TCC
interdigitated square device (left to right)

4.2 Gel electrophoresis
The first bench DNA ligation gave us a reference on which number of base pairs each
DNA brick should fall under approximately. After analyzing the electrophoretic migration
(figure 31), it has been concluded that Brick 1 and Brick 2 fall around 150 base pairs, while the
ligated brick falls under approximately 285 base pairs (between the 250 and 300 base pair mark):
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300
250
200
150

Number of
base pairs

Brick 1 Brick 2 Ligated
Ladder

4.8mm

Figure 4.3: Gel electrophoresis result of first bench DNA ligation
The second experiment conducted merged both daughter droplets containing DNA brick 1
and DNA brick 2 respectively on the DMF device. Since dispensing was not successful, 2μL
droplets were pipetted onto the device on the transport electrodes. The merged droplet was
incubated on the device first for one hour, then harvested for the next incubation steps and gel
electrophoresis with analysis. The result below suggests that the experiment was a success since
the same number of base pairs was identified for the merged droplet on the DMF device and the
ligated DNA on bench (figure 4.4).
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300
250
200
150
Number of
base pairs

Ladder

Brick 1

Brick 2

Ligated

4.8mm

Figure 4.4: Electrophoretic analysis showing the weight of the DNA brick in the merged droplet
to be the same as the ligated bricks on bench
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300
250
200
150

Number of
base pairs

Brick 1

Brick 2

Merged + Mixed Merged Only

Ladder
4.8mm

Figure 4.5: DNA Gel electrophoresis of a merged and mixed droplet on DMF device next
to a merged only on DMF device

The same experiment was repeated, this time mixing the merged droplet by moving it back
and forth on the device for a couple of minutes. The results confirm yet again that the ligation is
possible on the DMF device (figure 4.5).
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300
250
200
150

Brick 1
Ladder

Brick 2

Bench

Merge + Mix on
cleanroom DMF
4.8mm

Figure 4.6: DNA gel electrophoresis results for a bench ligation vs a ligation of a merged
and mixed droplet on a cleanroom DMF device
In parallel, the same successful experiment was also performed on a cleanroom fabricated
DMF device by Hee Tae An (figure 4.6). This suggests that IJP DMF devices may be able to
perform the same operations as the cleanroom fabricated DMF devices for a fraction of the cost
of manufacturing and be employed for some experiments that don’t require a complex device
structure.
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5.0 CONCLUSIONS
5.1 Summary
This study sought to investigate whether DNA ligation was possible on an inkjet-printed
digital microfluidic device, as a first step towards testing for oligonucleotide synthesis on a DMF
device.
The industrial partner Nuclera Nucleics created a DNA ligation protocol using water as
medium, rather than the traditional organic solvent acetonitrile. This opens the door to a potential
application in microfluidics, particularly in digital microfluidics, where droplets are individually
controlled to perform various operation such as splitting, merging, dispensing and moving.
Digital microfluidics is attractive as it requires less reagent and it can execute various tasks in a
short amount of time. This study specifically examined if this protocol could be adapted and
performed on inkjet-printed digital microfluidic devices, a low-cost alternative for cleanroom
fabricated digital microfluidic devices. These low-cost devices are manufactured in a shorter
amount of time and for a fraction of the cost compared to the traditional cleanroom devices. The
goal was to check whether the operations performed on a cleanroom fabricated DMF device can
also be performed on a low-cost IJP DMF device. Thus, a total of six designs were tested with DI
water droplets in order to make sure that basic operations such as moving and dispensing
droplets could be performed.
As stated in section 4.1, the dispensing/splitting of droplets on the IJP devices was not
successful on any device. However, moving/merging/mixing was successfully repeated
consistently on most devices, and the interdigitated variation of the TCC design was chosen to
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perform operations with droplets containing biological material for DNA ligation. As a result,
the droplets were pipetted on the transport electrodes for easier manipulation.
In order to verify whether the ligation on the DMF device was successful, it was necessary
to perform a bench top ligation using the protocol provided. A gel electrophoresis was then
executed to establish a reference for the migration of the DNA bricks individually and ligated
(figure 4.3). Two scenarios were then put in place for the experiment on DMF device: one where
the droplets containing DNA material are merged only, and one where they are merged and
mixed by moving the merged droplet back and forth on the device. The gel electrophoresis
comparison confirmed that the ligation is successful on the IJP DMF device for both scenarios,
as the electrophoresis migration of the ligated bricks was the same (figures 4.3, 4.4., 4.5).
Finally, the ligation tested in parallel on a cleanroom DMF device also presented the same results
(figure 4.6), suggesting that some operations can similarly be performed on the IJP device
without adversely affecting the outcome.

5.2 Contributions
The success of DNA ligation on a DMF device is just a stepping stone to the ultimate goal
of this research: performing oligonucleotide synthesis on a DMF device. Those DNA chains
currently have to be manually assembled by scientists and can be expensive and time-consuming.
Having easier access to fabricating long chains of DNA can further the advancements in
biomedical fields such as epigenetics and drug development. Adapting DNA synthesis on these
devices can alleviate the bottleneck created by the lack of supply vendors for long chains of
DNA (more than 3000 base pairs). Indeed, combining the aqueous chemistry created by Nuclera
Nucleics with the automatability of the DMF device could be a potential candidate for a “lab on
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a chip” device. The success of the DNA ligation on a DMF device shows that the chemical
innovation brought by the industrial partner is compatible with the fluid handling capabilities of
this type of device.

5.3 Future Work
The DNA ligation executed is but the first step in a larger scope. The end goal of this
research is to be able to synthesize oligonucleotide chains on the surface of the device directly,
by exploiting the novel aqueous chemistry combined with the DMF device operations. It is
possible that the next DNA synthesis procedures require magnetic beads as bases for building
longer chains, which will then require to be separated and washed between steps to get rid of any
excess reagent. The latter will occur by immobilizing the beads on the surface of the device
using a magnet, and by manipulating the washing buffer to pass over the beads. Preliminary
research regarding oligonucleotide synthesis and separation procedures on DMF devices has
been done in order to prepare for the future endeavors.
While oligonucleotide synthesis has not been performed in DMF devices, a similar process
of particle separation and washing has been performed in DMF immunoassays [22, 23].
Immunoassays use antibody-antigen interactions to bind biological material to a solid surface in
order to test for the presence and concentration of target proteins. This is useful for droplet
libraries and compound screens which provide tools for the function analysis of genomes,
individual proteins or complexes [36]. It is also useful for directed evolution of enzymes [37], or
DNA analysis and PCR (Polymerase Chain Reaction) [38]. However, immunoassays require a
large volume [29], a big cost and amount of time for each assay [5]. While Solid Phase
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Figure 5.1: DMF immunoassay and its control system [5]
Oligonucleotide Synthesis has not yet been carried out on DMF devices, it is useful to examine
how unbound reagents are frequently separated and/or washed away on the immunoassay device.
Magnetic filtration relies on the magnetic force of a magnet to hold the magnetic particles
in place while the separation takes place. In droplet-based magnetic immunoassays for instance,
a droplet of the sample and a droplet of the reagent containing the magnetic beads are merged
and incubated. After the formation of antibody-antigen complex, the magnetic beads are
immobilized and any unbound material is washed away (figure 5.2). A reagent droplet for
detection is added to quantitively evaluate the washing and retention efficiencies [28]. The
choice of magnet employed and its location are crucial design parameters in magnetic filtration
on DMF. A neodymium N48 grade with a 15.3lb pull force, 5/8 inches diameter and ¼ inch
thickness may be used [29]. Other neodymium N42 magnets with different pull forces (1.25lb,
5lb, 10lb) were also employed. They were positioned over and/or under the device when beads
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Figure 5.2: Example of magnetic filtration with use of antibody-antigen complexes [28]
needed to be held still, and removed to allow beads to resettle in the droplet [28]. The future
work is directed towards magnetic separation because it simplifies the microfabrication process
by eliminating either the physical barrier on the surface required for mechanical filtrations [39],
or the knowledge of “trap” locations in a confined geometry [25].
The separation and washing protocols are essential to ensure that the filtration has a maximum
yield. Two methods are reviewed for future research: serial dilution and supernatant washing. In
serial dilution washing, the DMF is used to merge and mix droplets of wash suspension with a
droplet of wash buffer. The magnet is positioned in such a way that particles are immobilized to
one side of the pooled droplet, and the droplet is then split into two daughter droplets. The
droplet not containing particles is put to waste. The bead droplet is then washed with a surfactant
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to prevent bead aggregation. The process is then repeated as needed (four [29] or five [28] times)
(figure 5.3). In supernatant separation washing, the particles are also mixed with wash
suspension solution, then immobilized by the magnet. The DMF is used to actuate the
supernatant droplet away from the magnet to waste, leaving particles on the device surface. Once
the magnet is removed, a droplet of wash buffer is added to resuspend the particles. The
supernatant is transported away and collected after every wash. Like serial dilution, the process
is then repeated as needed (figure 5.4).

Figure 5.3: Serial Dilution washing process [29]
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Figure 5.4: Supernatant separation washing protocol [29]

Washing efficiency is higher for supernatant washing than serial dilution. This means that less
washes are required to attain a desired threshold of reduction of unbound reactant when using
supernatant washing (figure 5.5). This washing protocol will likely be adopted as one of the
future aims of this research will surely include achieving the highest washing efficiency possible
on a DMF device for droplets containing DNA on magnetic beads with magnetic filtration.
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Figure 5.5: Comparison of efficiency of serial dilution vs supernatant separation [29]

Detection is a determining factor of success for testing the DMF device. It mainly consists
of using a fluorescent biological marker that binds to the magnetic beads. This marker is then
detected via chemiluminescence, using equipment to pick up a fluorescent signal. The intensity
of this signal is then correlated with the number of biological markers attached to the beads
present in the droplet [29]. Two types of efficiency can then be determined: a washing
efficiency, measuring how much unbound reagent is present in the waste droplet, and a retention
efficiency, measuring the bead loss during washing protocols. An example of detection
performed was via direct fluorescent label on a secondary antibody (FIA) or an enzyme labeled
secondary antibody (ELISA). The efficiency of the washing protocol was linked to the amount of
Horse Radish Peroxidase (HRP), the label for the magnetic beads (figure 5.6). Its presence was
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Figure 5.6: Example of detection graph presenting the evolution of concentration of
insulin vs chemiluminescence [28]
measured by adding Amplex Ultra red substrate to the supernatant wash droplets, and reading the
change in absorbance using a BioTEK Synergy plate reader [28].
Anticipating for the next years of research in this area, a tentative detection protocol has
been hypothesized. We will be using a fluorescent microscope and fluorescent dye instead of
biological markers. After adding the dye, we will be able to measure the intensity of the
fluorescent signals emitted. Two signals will be emitted from the device after reaching the dye
excitement wavelength: green and red for instance (figure 5.7). Since these lights emit at
different wavelengths, we will need two different filters. The red filter on the microscope will
allow the evaluation of the washing efficiency while the green filter will help quantify the
retention efficiency of the device (hypothetically).
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Figure 5.7: Sketch of microscope to measure signals after introducing fluorescent dye

We should be able to plot a graph representing the number of washes vs the ratio of the
fluorescent intensity after the wash to the initial intensity (I/I0) for each of the washing and
retention efficiencies. This will then give an idea of the percentage evolution after each wash.
We should expect an almost constant retention of beads (green) and an exponential decay-like
evolution for the washing efficiency (red) (figure 5.8).
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Figure 5.8: Example of efficiencies graph
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APPENDIX A
Supplemental Labview code employed to operate the DMF device:
(1) create/dispense droplets
(2) moving droplets
(3) dispensing and moving from two reservoirs

(1)

(2)
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(3)
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